Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-5,192
Closed -$405K 495
2024
Q1
$405K Buy
5,192
+517
+11% +$38.5K 0.01% 836
2023
Q4
$334K Buy
4,675
+178
+4% +$12.4K 0.01% 832
2023
Q3
$312K Buy
4,497
+81
+2% +$6.12K 0.01% 770
2023
Q2
$358K Buy
4,416
+190
+4% +$15.5K 0.01% 732
2023
Q1
$341K Sell
4,226
-23
-0.5% -$1.85K 0.01% 726
2022
Q4
$318K Buy
4,249
+12
+0.3% +$855 0.01% 686
2022
Q3
$274K Sell
4,237
-5
-0.1% -$346 0.01% 690
2022
Q2
$294K Buy
4,242
+1,567
+59% +$116K 0.01% 660
2022
Q1
$206K Buy
2,675
+44
+2% +$3.16K ﹤0.01% 858
2021
Q4
$201K Buy
+2,631
New +$193K ﹤0.01% 849
2021
Q3
Sell
-3,009
Closed -$201K 879
2021
Q2
$201K Buy
3,009
+310
+11% +$20.7K ﹤0.01% 814
2021
Q1
$201K Buy
+2,699
New +$205K 0.01% 761

Other funds holding HOLX

Lincoln National Corp's HOLX Position: Q2 2024 in Review

Lincoln National Corp sold out of Hologic (HOLX) in Q2 2024, closing a stake of 5,192 shares — an estimated $405K sold.

Lincoln National Corp first reported a position in HOLX in Q1 2021 and held it in 12 quarters. The position peaked at $405K in Q1 2024. 703 funds tracked by Wall St. Rank hold HOLX as of Q2 2024.

  • Lincoln National Corp reported no remaining Hologic position as of Q2 2024 after selling out during the quarter.
  • Lincoln National Corp sold 5,192 Hologic shares in Q2 2024, an estimated $405K.
  • Lincoln National Corp first reported a position in Hologic in Q1 2021 and held it in 12 quarters.
  • Lincoln National Corp's Hologic position peaked at $405K in Q1 2024.
  • 703 funds tracked by Wall St. Rank held Hologic as of Q2 2024.

Based on Lincoln National Corp's 13F filing for Q2 2024, filed 25 Jul 2024.